Professor David Handelsman
David Handelsman MB BS PhD FRACP FAHMS is Professor of Reproductive Endocrinology and Andrology (1996), founding Director of the ANZAC Research Institute (1998) and of Australia’s first Andrology Department at Concord Hospital (1999). A life member of the Endocrine Society of Australia and the Society for Reproductive Biology, he has served on the Australian Drug Evaluation Committee, WHO Human Reproduction Program and serves on the World Anti-Doping Agency Health, Medicine and Research Committee. His research into androgen physiology, pharmacology and toxicology spans basic, clinical and public health domains and has produced over 550 papers with >20,000 citations (h index 81). He is among the most highly cited authors worldwide on testosterone or androgens and in recent years has written invited editorial on testosterone for NEJM and JAMA.